90 related articles for article (PubMed ID: 1990677)
1. The diabetic "human reconstituted" severe combined immunodeficient (SCID-hu) mouse: a model for isogeneic, allogeneic, and xenogeneic human islet transplantation.
London NJ; Thirdborough SM; Swift SM; Bell PR; James RF
Transplant Proc; 1991 Feb; 23(1 Pt 1):749. PubMed ID: 1990677
[No Abstract] [Full Text] [Related]
2. Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection.
Shiroki R; Poindexter NJ; Woodle ES; Hussain MS; Mohanakumar T; Scharp DW
Transplantation; 1994 Jun; 57(11):1555-62. PubMed ID: 8009588
[TBL] [Abstract][Full Text] [Related]
3. Fifty islets maintain euglycemia and survive longer than 200 islets in allogeneic and xenogeneic diabetic hosts.
Ohzato H; Porter J; Monaco AP; Maki T
Transplant Proc; 1993 Feb; 25(1 Pt 2):953-4. PubMed ID: 8442277
[No Abstract] [Full Text] [Related]
4. Islets of Langerhans rejection: allo vs xenotransplantation in animals.
Bühler L; Deng S; Mage SR; Bubloz C; Rohner A; Morel P
Transplant Proc; 1994 Apr; 26(2):764-5. PubMed ID: 8171653
[No Abstract] [Full Text] [Related]
5. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.
Banuelos SJ; Shultz LD; Greiner DL; Burzenski LM; Gott B; Lyons BL; Rossini AA; Appel MC
Clin Immunol; 2004 Sep; 112(3):273-83. PubMed ID: 15308121
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies.
Zeng Y; Gage A; Montag A; Rothlein R; Thistlethwaite JR; Bluestone JA
Transplantation; 1994 Sep; 58(6):681-9. PubMed ID: 7940687
[TBL] [Abstract][Full Text] [Related]
7. Gamma-irradiation as a tool to reduce immunogenicity of islet allo- and xenografts.
Gotoh M; Kanai T; Dono K; Porter J; Maki T; Monaco AP
Horm Metab Res Suppl; 1990; 25():89-96. PubMed ID: 2088993
[TBL] [Abstract][Full Text] [Related]
8. Study of concordant xenografted islets of Langerhans rejection: humoral or cellular mechanism?
Deng S; Bühler L; Lou J; Grau G; Redard M; Bubloz C; Rohner A; Morel P
Transplant Proc; 1994 Jun; 26(3):1184-5. PubMed ID: 8029879
[No Abstract] [Full Text] [Related]
9. [Potentials of transplantation treatment in experimental and clinical diabetes mellitus (a review of the literature)].
Smirnov VV; Martynova MI; Mentkevich GL
Vopr Okhr Materin Det; 1980 Jul; 25(7):26-30. PubMed ID: 6774476
[No Abstract] [Full Text] [Related]
10. Beta cell destruction of pancreatic islets transplanted into diabetic BB/OK rats may be reflected by increased antibody-mediated anti-islet cytotoxicity.
Schröder D; Wanka H; Hehmke B; Klöting I; Köhler E; Knospe S; Schmidt S
Diabetes Res; 1990 Sep; 15(1):27-32. PubMed ID: 2132197
[TBL] [Abstract][Full Text] [Related]
11. Assessment of human islet viability using various mouse models.
Sabek OM; Fraga DW; Minoru O; McClaren JL; Gaber AO
Transplant Proc; 2005 Oct; 37(8):3415-6. PubMed ID: 16298612
[TBL] [Abstract][Full Text] [Related]
12. Islet xenograft destruction in the hu-PBL-severe combined immunodeficient (SCID) mouse necessitates anti-CD3 preactivation of human immune cells.
Gysemans C; Waer M; Laureys J; Depovere J; Pipeleers D; Bouillon R; Mathieu C
Clin Exp Immunol; 2000 Sep; 121(3):557-65. PubMed ID: 10971525
[TBL] [Abstract][Full Text] [Related]
13. Permanent acceptance of mitomycin C-treated islet allograft.
Matsuyama S; Gunji T; Ise K; Sato Y; Saito T; Gotoh M
Transplantation; 2003 Jul; 76(1):65-71. PubMed ID: 12865788
[TBL] [Abstract][Full Text] [Related]
14. Islet xenografting in autoimmune diabetes.
Gill RG; Coulombe M
Transplant Proc; 1994 Jun; 26(3):1140. PubMed ID: 7913256
[No Abstract] [Full Text] [Related]
15. Engraftment and survival of human islet xenografts irradiated with ultraviolet B in immunocompetent diabetic mice.
Sung RS; Fiedor PS; Yaron I; Zakheim AR; Quadracci KM; Goodman ER; Hardy MA
Transplant Proc; 1995 Dec; 27(6):3295-6. PubMed ID: 8539961
[No Abstract] [Full Text] [Related]
16. Interleukin 2 receptor-targeted therapy in islet transplantation research.
Hahn HJ; Kuttler B; Volk HD; Lucke S; Diamantstein T
Horm Metab Res Suppl; 1990; 25():177-80. PubMed ID: 2088963
[No Abstract] [Full Text] [Related]
17. Islet xenografts in mice and rats: I. Exocrine tissue is detrimental to engraftment and survival of human islet xenografts.
Nicolae M; Ketchum RJ; Jahr H; Janoff H; Brayman KL
Transplant Proc; 1994 Apr; 26(2):774. PubMed ID: 8171657
[No Abstract] [Full Text] [Related]
18. Immunoisolative effectiveness and limitation of agarose in a bioartificial pancreas.
Iwata H; Takagi T; Kobayashi K; Yang H; Ito F
Transplant Proc; 1994 Apr; 26(2):789. PubMed ID: 8171663
[No Abstract] [Full Text] [Related]
19. Role of adhesion molecules in islet allo- and xenograft rejection.
Gotoh M; Ohzato H; Fukuzaki T; Ohta Y; Nishihara M; Hasuike Y; Umeshita K; Sakon M; Yagita H; Okumura K; Miyasaka M; Monden M
Transplant Proc; 1996 Apr; 28(2):617. PubMed ID: 8623304
[No Abstract] [Full Text] [Related]
20. Immune response of diabetic patients against transplanted porcine fetal islet cells.
Kumagai Braesch M; Groth CG; Korsgren O; Andersson A; Hellerström C; Bjöersdorff A; Tibell A; Tollemar J; Bolinder J; Ostman J
Transplant Proc; 1992 Apr; 24(2):679-80. PubMed ID: 1566479
[No Abstract] [Full Text] [Related]
[Next] [New Search]
